GKOS

Glaukos Stock Price

40.23
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
40.23
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Glaukos Corporation GKOS NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
1.23 3.15% 40.23 38.61 40.25 38.97 39.00 18:35:44
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,756 562,742 $ 39.40 $ 22,173,577 738,657 23.31 - 84.65
Last Trade Time Type Quantity Stock Price Currency
19:00:00 65,704 $ 40.23 USD

Glaukos Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.78B 44.23M 31.47M $ 236.98M $ -40.86M 0.37 -43.55
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.97M $ - 0.00% -355.51k 1.30%

more financials information »

Glaukos News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GKOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week38.4740.2535.6537.70819,7101.764.57%
1 Month41.5041.9435.6538.61626,894-1.27-3.06%
3 Months32.9947.8231.5038.70728,5837.2421.95%
6 Months58.7570.9623.3140.62834,011-18.52-31.52%
1 Year75.4084.6523.3149.21652,346-35.17-46.64%
3 Years39.6984.6523.07547.44560,8400.541.36%
5 Years29.9084.6514.2543.51479,99510.3334.55%

Glaukos Description

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.


Your Recent History
NYSE
GKOS
Glaukos
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.